CIM in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with CIM today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Chimera Investment Corp. mainly owns U.S. residential mortgage loans and securities backed by mortgages. Residential loans make up most of its investment portfolio, with a substantial emphasis on older loans whose borrowers resumed regular payments after delinquency or default. Borrower payments supply the cash behind its investment income. Chimera borrows against assets to fund its holdings, so its main earnings depend on borrowers continuing to pay, investment yields exceeding borrowing costs, and lenders continuing to provide financing.
Its subsidiary HomeXpress also makes mortgages, mainly through independent mortgage brokers and bankers. It focuses on borrowers who do not meet traditional qualified-mortgage standards and investors financing rental properties. HomeXpress uses short-term financing to fund loans, then sells them to institutional investors without retaining servicing rights. It earns mainly from origination fees and loan-sale premiums, using sale proceeds to repay financing. This business depends on broker referrals and investors willing to buy the loans.
Chimera also earns investment-management and advisory fees through Palisades, a smaller business whose fees depend heavily on a limited number of institutional clients. Its real estate investment trust status requires it to meet asset and income tests and distribute most taxable income. Exemptions from investment-company registration also constrain the assets it can own and the businesses it can conduct.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
MFA Financial and Chimera both depend on homeowners’ repayments across substantial mortgage-loan portfolios, and both lend to property investors through subsidiaries. Watch demand for Lima One’s investor loans alongside HomeXpress’s lending to owners of rental properties.
Adamas Trust and Chimera both earn interest from mortgage investments and fees and sale gains from lending to residential property investors. Constructive’s revenue from making and selling rental-property loans offers a comparison for HomeXpress’s investor-lending business.
TPG Mortgage Investment Trust and Chimera share exposure to non-agency home loans: both invest in loans and package them into securities to raise funding, while Arc Home and HomeXpress make loans for sale. Arc Home’s income from originating and selling mortgages offers a read on the loan-sale conditions facing HomeXpress.
Redwood Trust and Chimera share the risks of lending to homeowners and residential property investors, then selling loans, packaging them into securities or holding them for interest income. Redwood’s mortgage banking income is a useful comparison for the economics of HomeXpress’s loan sales.
Ellington Financial and Chimera both earn from mortgage loans and securities alongside loan-origination businesses, so mortgage credit and financing conditions matter to both. Ellington’s Longbridge focuses on making, selling and servicing reverse mortgages, making its lending results less directly comparable with HomeXpress’s consumer and property-investor loans.
Annaly Capital Management and Chimera both borrow to invest in Agency mortgage securities and non-agency home loans, earning the difference between mortgage income and financing costs; both also have exposure to mortgage-servicing fees. Watch Annaly’s Agency investment spread as a comparison for Chimera’s growing financed Agency portfolio.
Rithm Capital and Chimera both combine home-loan origination and sales with mortgage investments, but Rithm has a much larger business collecting and administering mortgage payments. Newrez’s gains on loans made and sold are a closer comparison for HomeXpress than Rithm’s servicing income.
PennyMac Mortgage Investment Trust and Chimera both earn from residential mortgage investments and loan sales, but PennyMac emphasizes buying newly made prime-credit loans from lenders, pooling them and reselling them, alongside mortgage-servicing rights. Its loan-sale results offer a comparison for HomeXpress, though the borrower mix differs.
AGNC Investment is a benchmark for Chimera’s growing Agency mortgage business: both borrow against securities backed by guaranteed home-loan payments to earn investment income. Watch AGNC’s borrowing costs against its mortgage income—the same funding pressure accompanies Chimera’s Agency purchases.
Dynex Capital and Chimera both hold Agency home-loan securities, so interest rates and borrowers’ early repayments affect their cash flows and values. Dynex’s fixed-rate securities pass borrowers’ principal and interest through to investors; changes in those cash flows help frame the risks in Chimera’s Agency holdings.
Invesco Mortgage Capital and Chimera both use borrowed money to hold Agency mortgage securities, making the gap between mortgage income and funding costs important to both. Invesco’s investment returns after funding costs offer a comparison for this increasingly substantial part of Chimera’s portfolio.
Orchid Island Capital shares the income-spread and valuation risks of Chimera’s Agency mortgage holdings, borrowing to invest in securities backed by guaranteed home-loan payments. Orchid’s net interest margin shows how much mortgage income remains after borrowing costs in its leveraged Agency portfolio.
ARMOUR Residential REIT and Chimera both borrow to invest in Agency mortgage securities and use hedges to manage interest-rate risk. ARMOUR’s financing and hedging results provide a comparison for the costs and protection around Chimera’s Agency mortgage income.
Annaly Capital Management. Inc. earningsNLY
Annaly Capital’s report will show how income on its Agency mortgage investments compares with funding costs, a market read-through for Chimera’s Agency holdings.
Watch Annaly Capital’s Agency investment spread—the room between mortgage income and funding costs. If it holds or widens, conditions are more supportive for this type of asset, easing a pressure also faced by Chimera’s Agency securities; if it narrows, funding costs are taking a larger bite. Chimera’s asset mix and hedges differ, so Annaly’s result is not a proxy for Chimera’s earnings, but it helps show the direction of shared funding pressure.
Rithm Capital Corp. earningsRITM
Rithm Capital’s report will show what Newrez earns from originating and selling mortgages, a read-through for HomeXpress’s loan-sale business at Chimera.
Read Newrez’s loan production alongside the income it earns from originating and selling mortgages. Production supported by steady sale gains suggests lenders can still turn new loans into income, a favorable sign for HomeXpress’s originate-to-sell model; weaker production or sale gains would point to a tougher market for its loan sales. The borrower mix and scale differ, so Newrez is a market signal, not a stand-in for HomeXpress.
Fed Interest Rate Decision
Chimera earns interest on mortgage and real-estate investments and pays to finance them, so the Fed’s decision on its benchmark short-term rate can change financing costs faster than income from its assets and affect its net interest margin.
Expected4.0%Last release4.0%
If it comes in above expectations
If the Fed sets its rate above expectations, higher rates may raise Chimera’s borrowing costs faster than interest income on its mortgage and real-estate investments adjusts, squeezing the margin between what it earns and pays.
If it comes in below expectations
If the Fed sets its rate below expectations, cheaper borrowing may ease pressure on Chimera’s financing costs relative to interest income from its mortgage and real-estate investments, supporting the margin between what it earns and pays.
Chimera Investment Corp. earningsThis company
Chimera’s report will show whether income from mortgage investments holds up after financing costs and whether HomeXpress earns gains by selling the loans it originates.
Read the investment portfolio’s interest income after financing costs alongside its net interest margin, then compare HomeXpress’s loan production with the net gains it earns from originating and selling loans. Steady portfolio figures show mortgage income is still covering its funding costs; solid sale gains on meaningful production show HomeXpress is turning loans into income. If portfolio income or margin weakens, financing is taking a larger bite; if production rises but sale gains fade, HomeXpress is not converting added lending into comparable income.
Adamas Trust, Inc. earningsADAM
Adamas Trust, Inc.’s report will show how its rental-property lending and loan sales are faring, a read-through for HomeXpress’s investor-property loans at Chimera.
Read Adamas’s rental-property loan production alongside the income it earns from selling those loans. If both hold up or improve, investor-borrower demand and loan-sale channels in this niche appear supportive for HomeXpress’s investor-purpose loans; if production or sale income weakens, that part of HomeXpress’s business may find growth or profitable sales harder. Adamas does not tell readers how demand for HomeXpress’s consumer Non-QM loans is doing.